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Abstract
Trimethyltin (TMT), which has a variety of applications in industry and agricultural is a 
neurotoxin that is known to affect the auditory system as well as central nervous system (CNS) of 
humans and experimental animals. However, the mechanisms underlying TMT-induced auditory 
dysfunction are poorly understood. To gain insights into the neurotoxic effect of TMT on the 
peripheral auditory system, we treated cochlear organotypic cultures with concentrations of TMT 
ranging from 5 to 100 μM for 24 h. Interestingly, TMT preferentially damaged auditory nerve 
fibers and spiral ganglion neurons in a dose-dependent manner, but had no noticeable effects on 
the sensory hair cells at the doses employed. TMT-induced damage to auditory neurons was 
associated with significant soma shrinkage, nuclear condensation and activation of caspase-3, 
biomarkers indicative of apoptotic cell death. Our findings show that TMT is exclusively 
neurotoxicity in rat cochlear organotypic culture and that TMT-induced auditory neuron death 
occurs through a caspase-mediated apoptotic pathway.
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Introduction
Organotin compounds (OTCs) are wieldy used in industrial and agricultural settings as 
plastic stabilizers, pesticides, timber preservatives, and antifouling paints. Due to their 
widespread application during the past 50 years a considerable amount of OTCs have been 
introduced into the environment (Hoch, 2001). As most of OTCs are toxic, these harmful 
contaminants pose great risk for human health and the ecosystem (Braman and Tompkins, 
1979, Cima, 2011). Among these potentially toxic compounds, trimethyltin (TMT) has 
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received considerable attention as numerous studies have demonstrated it can act as a potent 
neurotoxin.
TMT is a trialkyl-tin compound that mainly damages the central nervous system (Koczyk, 
1996). TMT selectively induces neuronal death in the human and animal limbic system 
particularly in the hippocampus (Geloso et al., 2011a). Humans occupationally exposed to 
TMT develop a limbic-cerebellar syndrome characterized by hearing loss, disorientation, 
amnesia, aggressive behavior, complex partial and tonic-clonic seizures, ataxia and mild 
sensory neuropathy (Dorman, 2000). In experimental animals TMT intoxication produces a 
similar syndrome with spontaneous-seizures, self-mutilation, vocalizations, hyperactivity 
and aggressive behavior (Dyer et al., 1982). A number studies with neural cell lines and 
primary cultures indicate that TMT exposure produces changes indicative of programmed 
cell death such as nuclear condensation, DNA fragmentation, membrane blebbing, and 
caspase activation (Jenkins and Barone, 2004, Kuramoto et al., 2011, Mundy and 
Freudenrich, 2006). Similar neuronal pathologies were seen in vivo when TMT was given to 
rat and mice (Fiedorowicz et al., 2001, Morita et al., 2008). Although the mechanisms 
underlying the neurotoxicity of TMT are still obscure, the damage induced by TMT in 
neurons is thought to involve several pathways such as oxidative stress, intracellular calcium 
overload, and mitochondrial damage (Aldridge et al., 1977, Ali et al., 1992, Misiti et al., 
2008, Piacentini et al., 2008). In addition, expression of stannin (Snn), a mitochondrial 
membrane protein mainly localized to cells with TMT sensitivity appears to play an 
essential role in TMT-mediated selective neuronal degeneration (Davidson et al., 2004, 
Toggas et al., 1992).
In addition to CNS injury, TMT can damage the peripheral auditory system (Chang and 
Dyer, 1983b). A single 4–6 mg/kg dose of TMT produced a frequency-dependent hearing 
loss that was most severe in the high frequency range (Eastman et al., 1987, Ruppert et al., 
1984). TMT-induced high frequency hearing loss was closely correlated with loss of the 
outer hair cells (OHC) in the basal turn of the cochlea (Crofton et al., 1990, Hoeffding and 
Fechter, 1991). Moderate doses of TMT induced hearing loss that but partially reversible; 
however, the recovery period measured by startle reflex audiometry was uncharacteristically 
prolonged (Young and Fechter, 1986). Apart from OHC loss, both the known neurotoxic 
effects and the acute disruption of compound action potential (CAP) by TMT suggest a 
possible mechanism involving direct injury to auditory neurons in addition to the OHC 
(Fechter and Liu, 1995). To evaluate the relative toxicities of TMT on neurons versus 
sensory hair cells within the cochlea, rat postnatal cochlear organotypic cultures were 
exposed to varying concentrations of TMT to assess the relative damage to auditory nerve 
fibers (ANF) and SGN compared OHC and inner hair cells (IHC).
Materials and methods
Cochlear organotypic cultures
Postnatal day 3 (P3) SASCO Sprague-Dawley rats purchased from Charles River 
Laboratories were used for preparing cochlear organotypic cultures as described previously 
(Ding et al., 2011). In brief, after rat pups were decapitated, the cochleae were quickly 
removed and the whole basilar membrane containing the organ of Corti, auditory nerve 
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fibers (ANF) and SGN were carefully dissected out and transferred on to rat tail collagen gel 
in a culture dish. Approximately 10 μl of collagen gel (type I collagen gel 3.76 mg/ml in 
0.02 N acetic acid, 10x basal medium eagle, 2% sodium carbonate, at 9:1: 1 ratio) was 
applied to the surface of a 35 × 10 mm culture dish and allowed to gel for about 30 min at 
room temperature. Afterwards, 1.3 ml of serum-free medium (0.01 g/ml bovine serum 
albumin (Sigma A-4919), 1% serum-free supplement (Sigma I-1884), 1% 200 mM 
glutamate, 2.4% of 20% glucose, 0.2% penicillin G, 95.4% 1X basal medium eagle (Sigma 
B-15220) was added to the culture dish. The basilar membrane containing the sensory hair 
cells, SGN and supporting cells was placed on the surface of the collagen gel and then 
maintained in an incubator at 37 °C and 5% CO2 overnight. On the following day, fresh 
culture medium (2 ml) with or without various concentrations of TMT was added to each 
dish and cochlear explants were cultured for an additional 24 h.
Trimethyltin treatment
Cochleae were randomly divide into 5 groups (n = 10 per group). One group served as 
normal control; the other four groups were treated with different concentrations of TMT. 
TMT stock solution was freshly prepared at a concentration of 10 mM in serum-free 
medium and diluted to a final concentration of 0 (control) 5, 10, 50 or 100 μM for each TMT 
treated group. Explants were cultured in the incubator for 24 h and then harvested for 
histological analysis.
Immunohistochemical staining
Cochlear explants were fixed with 10% formalin for 2 h at 4 °C and rinsed three times in 0.1 
M phosphate buffered saline (PBS). To stain neurofilaments, which are expressed in both 
type I and type II SGN and ANF as well as efferent fibers, specimens were immersed 
overnight at 4 °C in a monoclonal primary mouse 200 kD anti-neurofilament antibody 
(Sigma, No142) diluted in 1% Triton X-100 and 5% goat serum in 0.1 M PBS (1:100). 
Specimens were rinsed three times with PBS and incubated for an additional 2 h at room 
temperature in a secondary goat anti-mouse antibody conjugated with Alexa Fluor488 (Life 
technologies, A11001) diluted in PBS (1:200). To stain hair cell stereocilia and cuticular 
plate, specimens were rinsed in PBS three times and incubated for 1 h at room temperature 
with Alexa Fluor 568 conjugated phalloidin (Life technologies, A12380) diluted in PBS 
(1:200). After rinsing in PBS, the specimens were immersed for 30 minutes in fresh To-
Pro-3 solution (Life technologies, T3605, 1 mM in 0.75 ml DMSO diluted in 1 ml H2O) to 
label the nuclei of cells in the specimen. Specimens were subsequently mounted on glass 
slides in glycerin, coverslipped and examined under a confocal microscope.
Cochleograms
Cochlear hair cells were observed and counted under a fluorescent microscope with the 
appropriate filter to visualize the stereocilia and cuticular plate of hair cells labeled with 
Alexa Fluor 568 conjugated phalloidin. The number of hair cells were counted over 0.24 
mm intervals along the enter length of the basilar membrane from apex to base. Plots 
showing the percent IHC and OHC loss as a function of percent distance from the apex of 
the cochlea were used to construct cochleograms. Cochleograms for each treatment were 
Yu et al. Page 3













averaged to generate a mean cochleogram using custom software (Dong et al., 2014, Wang 
et al., 2014).
Caspase-3 staining
To evaluate caspase-3 activity in SGNs, cochlear explants in control and the 50 μM TMT 
group were labeled with a cell permeable fluorogenic caspase substrate, Red-VAD-FMK 
caspase, using a CaspGLOW Red Active Caspase Staining Kit (BioVision, K190) following 
the manufacturer instructions. Twelve hours after treatment, the unfixed specimens were 
incubated with Red-VAD-FMK caspase-3 diluted in culture medium (1:200) at 37 °C and 
5% CO2 for 60 min, then rinsed three times with wash buffer and fixed in 10% formalin for 
2 h. To optimize contrast, the red fluorescence of activated caspase-3 was converted with 
software to green pseudo-color in the photomicrographs. Specimens were immunolabeled 
with an antibody against neurofilament 200 kD (see above), rinsed in PBS, mounted in 
glycerin on glass slides and coverslipped.
Confocal microscopy
Cochlear specimens were examined under a confocal microscope (Zeiss LSM-510 Meta) 
using appropriate filters to detect the green fluorescence of Alexa Fluor 488 labeled 
neurofilament (excitation 488 nm, emission 519 nm), red fluorescence of Alexa Fluor 568 
labeled phalloidin (excitation 578 nm, emission 600 nm), purple fluorescence of To-Pro-3 
labeled nucleus (excitation 642 nm, emission 661 nm) and red fluorescence for caspase-3 
(excitation 540 nm, emission 570 nm). As described previously, confocal images were 
processed using Confocal LSM Image Examiner and Adobe Photoshop CS 3.0 software as 
described previously (Ding et al., 2014, Dong et al., 2014, Wang et al., 2014).
Statistical Analysis
ANF and SGN counts were evaluated using a one-way analysis of variance (GraphPad 
Prism 5) and Newman-Keuls post-hoc analysis as described below.
Results
TMT damages ANF and SGN
To determine its neurotoxic effects on cochlear ANF, SGN and hair cells (HC), cochlear 
cultures were treated with 50 μM TMT for 24 h. Fig 1 illustrates the typical status of IHC 
and OHC, ANF and SGN from the upper middle turn of the cochlea in control cultures and 
those treated with 50 μM TMT. In control cultures, the stereocilia bundle and cuticular plate 
of both the IHC and OHC were heavily labeled with phalloidin (red). The three rows of 
OHC and one row of IHC were arranged longitudinally in a gently curving arc; there was no 
sign of HC loss or damage. The peripheral ANF which project out radially to the hair cells 
from the SGN were intensely labeled with neurofilament 200 kD (green). The radial ANF 
were organized into smooth and thick fascicles. The SGN in normal control cultures had 
large, round or oval-shaped soma with heavy neurofilament labeling of the cytoplasm and 
faint labeling of the nucleus (Fig. 1A). Remarkably, in cultures treated with TMT for 24 h, 
the IHC and OHC maintained their normal structure and position; there was no obvious loss 
or damage to the HC. In contrast, TMT caused massive degenerative changes in the ANF 
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and SGN (Fig. 1B). After 24 h treatment with 50 μM TMT, most ANFs were fragmented 
and pixelated with nearly total loss of most peripheral fibers endings approaching the hair 
cells. The number of SGN was greatly reduced and the soma of the remaining SGN were 
shrunken and condensed and the nucleus seldom visible.
Cochleograms
To evaluate the effect of TMT on cochlear HC, average cochleograms (N = 5/group) 
measuring the percentage of missing OHC and IHC as a function of percent distance from 
the apex of the cochlea were constructed after 24 h treatment with various concentrations of 
TMT. The mean loss of OHC and IHC for the control group (Fig. 1C) was less than 5% 
along the basilar membrane except for the extreme base and apex of the cochlea; losses in 
these regions are mainly due to mechanical damage during cochlear dissection. Mean losses 
of OHC and IHC in the 5, 10, 50 and 100 μM groups were similar to the control group as 
illustrated in Figure 1D for the 50 mM TMT dose. Mean cochleograms for all TMT doses 
were similar to Figure 1D. HC loss did not increase with TMT dose and even at the highest 
concentration.
Dose-dependent ANF damage
Since neurofilaments are heavily expressed in neurons, our neurofilament antibody would be 
expected to label type I and type II ANF as well as efferent fibers. Since the vast majority of 
fibers innervating the cochlea are type I (90–95%) or type II (5–10%) afferents, our 
neurofilament labeling predominantly represents the effects of TMT on ANF (Brown and 
Ledwith, 1990, Perkins and Morest, 1975, Spoendlin and Gacek, 1963). Figures 2A–E 
shows the condition of ANF in the upper middle turn of the cochlea after 24 h in culture; 
data are shown for controls and those treated with varying concentrations of TMT. In control 
cultures, the ANF fascicles were thick and smooth (Fig. 2A). However, in TMT treated 
cultures, the ANF fascicles degenerated in a dose-dependent manner (Fig. 2B–E). In cultures 
treated with 5 μM TMT, a slight decline in ANF density was evident, many blebs were 
present on the surviving fibers and fiber thickness had decreased. As TMT concentration 
increased, the numbers of surviving fibers decreased, the ANF fascicles became thinner and 
blebbing and fragmentation of ANF increased. At the highest TMT concentration, 100 μM, 
nearly all of the ANFs were absent and only the debris of ANF fascicles remained. 
However, a few intact fibers were still present at the highest concentration; these TMT-
resistant fibers could conceivably represent type II fibers. Type II afferent fibers, which can 
be detected with an antibody against peripherin, tend to be resistant to trauma (Barclay et al., 
2011, Lim, 1976).
Since TMT-induced damage to ANF was similar along the length of the cochlea, we 
quantified the numbers of surviving ANF in the upper middle turn of the cochlea; ANF were 
measured per 140 μm widths in control and TMT-treated samples. Figure 2F shows the 
mean numbers (n = 14/group) of ANF/140 μm in control cultures and cultures treated with 
various concentration of TMT. In control cultures, approximately 63 fibers were present per 
140 μm. The mean numbers of ANF/140 μm decreased in a dose-dependent manner and at 
100 μM TMT only 4.7 fibers were present per 140 μm. A one-way analysis of variance 
(ANOVA) showed there was a statistically significant effect of TMT treatment on ANF 
Yu et al. Page 5













survival (one-way ANOVA, P < 0.0001, F = 246.6). A Newman-Keuls post hoc test showed 
that the mean numbers of ANF in all comparison pairs were significantly different 
(Newman-Keuls post-hoc analysis, P < 0.05).
Dose-dependent SGN degeneration
Fig. 3 illustrates the status of SGN in the upper middle turn of the cochlea of control cultures 
and cultures treated with TMT for 24 h. The SGN in control cultures had large and round or 
ovoid cell bodies; strong neurofilament 200 kD immunolabeling was present throughout the 
cytoplasm except for the nucleus (Figure 3A). However, in TMT treated cultures, SGN 
soma size decreased with increasing TMT dose and at the higher doses, the size of the 
nucleus was substantially smaller than normal (Fig. 3B–E). After treatment with 100 μM 
TMT, nearly all SGNs were destroyed (Fig. 3E).
Since TMT-induced damage to SGN was similar along the length of the cochlea, we 
measured the density of SGN in the upper middle turn of the cochlea using procedures 
previously described (Wang et al., 2014). Figure 3F shows the mean numbers (n=10/group) 
of SGN per 105 μm3 in control cultures and those treated with varying TMT concentrations. 
In control cultures, there were approximately 47 SGN per 105 μm3. However, in TMT 
treated cultures, the mean numbers of SGN decreased in a dose-dependent manner so that at 
the 100 μM TMT dose there were ~3 SGN per 105 μm3. There was a significant effect of 
TMT treatment on SGN survival (one-way ANOVA, P < 0.0001, F = 74.68). SGN densities 
were also significantly different between the different TMT concentrations (Fig. 3F, 
Newman-Keuls post-hoc analysis, P < 0.05).
TMT-induced morphological changes
Figure 4 illustrates the characteristic morphological features of SGN before and after TMT 
treatment. SGN were labeled with a neurofilament primary antibody and Alexa 488 
secondary antibody (green). The nuclei of all cells were labeled with To-Pro-3; the normal 
blue fluorescence of To-Pro-3 was converted to red pseudo-color with software to enhance 
contrast. In control cultures, the SGN soma had a large round or ovoid shape (Figure 4A). 
The cytoplasm within the SGN was heavily labeled with neurofilament 200 kD, the round or 
ovoid shaped nucleus in the center of the soma was heavily labeled by To-Pro-3 and ANF 
were labeled with neurofilament. However, in the TMT treated cultures, SGN somas were 
greatly reduced in size with most neurites missing, and the SGN nuclei remarkably 
condensed (Fig. 4B).
To quantify the soma shrinkage, the cross sectional area of SGN soma was measured as 
previously reported (Wei et al., 2010). The histograms in Figure 5A–E show the numbers of 
SGN vs. soma size (n = 200 cells/group) in control cultures and cultures treated for 24 h 
with various concentrations of TMT. In controls, most SGN soma areas ranged from 150 
μm2 to 250 μm2 with the major peak located at 200 μm2. In the TMT treated cultures, 
however, the distribution of SGN soma areas gradually shifted towards smaller values with 
increasing TMT dose. After treatment with 100 μM TMT, nearly all SGN had shrunken so 
that the major peak had decreased to 50 μm2. Figure 5F shows the mean size of SGN somas 
in control cultures and cultures treated with various TMT concentrations. TMT treatment 
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caused a dose-dependent decrease in SGN soma size. Statistical analysis revealed a 
significant treatment effect (one-way ANOVA, P < 0.0001, F = 198.4). The differences in 
SGN soma sizes between all compared groups were statistically significant (Newman-Keuls 
post-hoc analysis, P < 0.05).
Caspase-3 activation induced by TMT
A fluorogenic probe was used to detect activated executioner caspase-3 in cochlear cultures. 
When the fluorogenic probe was left out of the culture, there was a complete absence of 
green caspase-3 labeling in the negative control (Figure 3A). When the fluorogenic probe 
was added to positive control cultures (Figure 6B), green caspase-3 labeling was present on 
some non-neuronal cells (negative for neurofilament 200 kD, dashed squares). However, a 
few shrunken SGN which stained positive for neurofilament and caspase-3 (circles, green/
yellow) were detected. After 12 h treatment with 50 μM TMT, there were many 
neurofilament-positive, shrunken SGN with apoptotic features; these cells exhibited green/
yellow cytoplasmic labeling (open circles) indicative of caspase-mediated programmed cell 
death. Green caspase-3 labeling was also present in non-neuronal cells (dashed square, 
neurofilament negative)
Discussion
TMT is one of a several alkyltin derivatives that have a variety of industrial applications 
which include heat stabilizers in polyvinylchloride tubing, curing agents for rubber 
production, disinfectants in hospitals, and biocides. Human exposure to these compounds 
can result in a variety of clinical disorders resulting from damage or destruction of cells in 
the central nervous system, immune system, spleen, lung, and kidney (Brown et al., 1979, 
Geloso et al., 2011b, Philbert et al., 2000, Snoeij et al., 1985). The distinct range of cellular 
targets of these compounds make these toxins somewhat unique as they are structurally 
related though mechanistically function quite differently. Some of these differences can be 
attributed to divergences in their hydrophobicity which has the potential to control their 
toxic behavior (Komulainen and Bondy, 1987, Mushak et al., 1982). Differences in the 
affected targeted organs identified for each derivative implies there are distinct biochemical 
pathways disrupted within these cells resulting in the toxic specificity. For example, TMT 
preferentially induces neuronal damage whereas dimethyltin (DMT) induces myelin edema 
and astrocytes degeneration (O’Callaghan et al., 1989). The reason for this is unclear as 
TMT exposure as well as other alkyltin derivatives can all provoke mitochondrial 
dysfunction and increase ROS, yet the final disrupted tissues are different (LeBel et al., 
1990, Stine et al., 1988). It has been suggested that the intrinsic discrepancy between 
susceptibility of neuronal and other cells to TMT may be dependent on differential 
regulation of the mitochondrial permeability transition pore (Qu et al., 2011). The lack of 
TMT damage to postnatal hair cells may be related to the immature development of proteins, 
cellular organelles such mitochondria and aerobic respiration (Bruce et al., 2000, Ito et al., 
1995, Weaver and Schweitzer, 1994). This hypothesis could be tested by applying TMT to 
more mature cochlear cultures. Another possibility is that Snn, a transmembrane protein that 
sensitizes cells to TMT damage, is not expressed in postnatal hair cells (Billingsley et al., 
2006, Buck-Koehntop et al., 2005, Davidson et al., 2004, Toggas et al., 1992). This 
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hypothesis could be evaluated by evaluating developmental changes in Snn expression in 
hair cells. A third possibility is that postnatal hair cells can be damaged by TMT, but only at 
higher doses or longer treatment durations than those employed in this study. This could be 
tested by using higher doses of TMT or applying TMT for longer durations.
Although TMT toxicity has been extensively studied characterization of the actual molecular 
processes and its intracellular targets have not been adequately described. In general, TMT 
toxicity results in apoptotic cell death, which includes chromatin condensation, nuclear 
fragmentation, mitochondrial dysfunction, ROS production, membrane blebbing, and 
caspase activation (Geloso et al., 2002, Jenkins and Barone, 2004). TMT selectively 
destroyed neurons located in several brain areas including the neocortex, amygdala, and 
olfactory tubercle, although the most prominent effects were seen in the hippocampus 
(Balaban et al., 1988, Brown et al., 1979, Thompson et al., 1996). Recent studies suggest 
that the highly conserved, 88-amino acid protein, Snn may mediate the selective toxicity of 
organotins (Buck-Koehntop et al., 2005, Davidson et al., 2004, Toggas et al., 1992). This is 
based on the observation that Snn predominates in tissues with high toxicity to TMT, which 
include the CNS, immune system, spleen, kidney and lung but is essentially lacking in cells 
that exhibit considerable resistance to TMT. Snn peptide has been shown to bind TMT in a 
1:1 ratio and can dealkylate TMT to DMT (Davidson et al., 2004). Transfection of TMT-
resistant NIH-3T3 mouse fibroblasts with Snn increased cytotoxicity to both TMT and 
DMT. The selective localization of Snn, along with its mitochondrial localization, coupled 
with its ability to bind and dealkylate TMT, suggests a possible mechanism by which 
alkyltin toxicity may be mediated.
In the context of hearing and the inner ear, TMT induces a permanent hearing loss and 
cochlear damage which is most pronounced at the high frequencies (Chang and Dyer, 1983a, 
Eastman et al., 1987, Ruppert et al., 1984). Consistent with this is the observation that OHC 
in the base of the cochlea appear to be sensitive to TMT toxicity (Crofton et al., 1990, 
Fechter and Liu, 1995, Hoeffding and Fechter, 1991). Taken together, these results suggest 
that TMT is mainly toxic to hair cells in adult animals, although there is evidence that is also 
damages SGN (Chang and Dyer, 1983b). On the other hand, the acute effects of TMT in 
vivo indicate that it has limited effects on both the cochlear microphonic generated by the 
OHC, the endolymphatic potential generated by the stria vascularis and the summating 
potential largely generated by IHC (Clerici et al., 1991, Durrant et al., 1998, Fechter and 
Liu, 1994). In contrast, TMT rapidly reduced the CAP. Since the CAP reflects the summed 
neural response from the auditory nerve, these results suggest that the acute effects of TMT 
predominantly damage the SGN consistent with our in vitro results. The large TMT-induced 
effects on the CAP occurred at a dose of 0.2 mg/kg, equivalent to 1.5 μM assuming a 
uniform distribution throughout the body (Fechter and Liu, 1994). This predicted dose is 
only slightly lower than the 5 μM TMT dose that caused a 30% loss of SGN (Fig. 3F). 
Given the obvious experimental differences (e.g., postnatal vs. adult, function vs. structure), 
the TMT anatomical damage seen in our cochlear cultures is in reasonable accord with the 
CAP data.
The TMT toxicity profile in the developing inner ear is largely unknown. Because of the 
known neurotoxic profile of TMT in the CNS, it is also reasonable to speculate that auditory 
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neurons within the developing cochlea may, in fact, be a more sensitive target to this alkyltin 
derivative. To test this hypothesis, we used rat postnatal cochlear organotypic culture as a 
model system to determine the selective neurotoxic actions of TMT on the hair cells, 
supporting cells and neurons in the cochlea. Our results clearly demonstrate that TMT 
preferentially destroys ANF and SGN in rat cochlear cultures in a dose-dependent manner. 
Qualitatively, damage to SGN and ANF appeared relatively uniform along the length of the 
cochlea; therefore we quantified SGN and ANF losses in the middle of the cochlea. SGN 
and ANF degeneration occurred at concentrations as low as 5 μM after only 24 h treatment 
and nearly all the ANF and SGN were destroyed after 24 h treatment with 100 μM TMT. In 
contrast to prior studies in adult rats, there was little or no damage to either OHC or IHC 
even at the highest TMT concentration of 100 μM that destroyed virtually all SGN. This is 
not totally surprising as hair cells share some similarities with astrocytes, which contain the 
astrocytic marker, glial fibrillary acidic protein (GFAP) (Moriya et al., 1993) and are less 
sensitive to TMT toxicity (Gunasekar et al., 2001).
The mechanisms underlying the differences in TMT sensitivity between postnatal vs. adult 
SGN and hair cells are currently unknown. As noted above, similarities shared with 
astrocyte may promote the survival of hair cells relative to neurons after TMT exposure. 
Additionally, it has been demonstrated that hippocampal neurons containing the calcium-
binding protein calretinin (CR) and parvalbumin (PV) are resistant to TMT-induced 
neuronal degeneration whereas those containing calbindin (CB) are selectively damaged by 
TMT (Geloso et al., 1996, 1997). In contrast, both PV and CB-positive neurons are sensitive 
to TMT neurotoxicity and only CR-positive neurons are resistant (Geloso et al., 1998, Reuhl 
et al., 1983). This, however, seems unlikely to account for this difference in the cochlea 
because CR and PV are also highly expressed by SGN (Dechesne et al., 1991, Soto-Prior et 
al., 1995). Unfortunately, expression of Snn, identified as a critical factor in TMT-induced 
selective cytotoxicity in neurons in the CNS (Davidson et al., 2004, Reese et al., 2005) has 
not been measured in the inner ear. Thus, further studies are needed to determine which cells 
in the cochlea express Snn and whether Snn expression changes during development.
Our data further demonstrate, for the first time, that TMT induces SGN cell death by 
apoptosis in cochlear cultures. TMT exposure caused significant morphological alterations 
in SGN characterized by soma shrinkage and nuclear condensation, morphological 
hallmarks of cells undergoing apoptosis. In addition, activation of caspase-3, a major 
executioner in the caspase-dependent apoptotic pathway, was also observed in the SGN 
during the early stage of TMT treatment, consistent with prior findings in CNS (Fiedorowicz 
et al., 2001, Jenkins et al., 2004). TMT exposure has also been shown to enhance ROS 
formation leading to apoptotic cell death in a number of different cell lines and primary 
cultures (Wang et al., 2008, Zhang et al., 2006). ROS production could damage 
mitochondria and activate an apoptotic pathway mediated by the activation of mitochondrial 
permeability transition pore, release of cytochrome c and activation of effector caspase-3 
(Qu et al., 2011). Consistent with ROS involvement, TMT-induced neuronal apoptosis can 
be reduced by antioxidants that reduce ROS expression (Cookson et al., 1998, Qu et al., 
2011, Shin et al., 2005).
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Model of SGN Degeneration
Our results clearly demonstrated that TMT selectively destroys ANF and SGN in P3 
cochlear organotypic cultures in a dose-dependent manner. Since there was no evidence of 
hair cell damage even at the highest dose employed, 100 μM, TMT could conceivably be 
used to develop several experimental models of selective SGN death. If TMT were applied 
to the round window of the postnatal cochlea, it could conceivably result in partial 
destruction of SGN with retention of OHC and IHC. In cases such as this, the cochlear 
amplification and sharp tuning provided by the OHC would remain intact, but the neural 
input to the central nervous system would be greatly reduced creating a model that could be 
used to examine the perceptual and electrophysiological consequences of sensory 
deprivation (Lobarinas et al., 2013). Efforts are underway to use stem cells and trophic 
factors to regenerate SGN and their peripheral ANF (Diensthuber et al., 2014). The TMT 
model of selective SGN degeneration could conceivably be used as experimental platform to 
determine if and how stem cells form synaptic connections to hair cells in the organ of Corti 
and neurons in the cochlear nucleus. Efforts aimed at replenishing missing SGN are critical 
for the transmission of acoustic or electrical stimulation from the cochlea to the auditory 
brainstem (Bas et al., 2014, Berkingali et al., 2008, Schmiedt et al., 2002, Zhang et al., 
2013).
Summary
Our results show that TMT selectively damages SGN and ANF in postnatal rat cochlear 
cultures without damaging the hair cells. Whether local application of TMT produces a 
similar pattern of damage in vivo in postnatal or adult cochlea remains an important 
unanswered question. TMT-induced auditory neuronal death occurs via a caspase-mediated 
apoptotic cell death pathway consistent with soma shrinkage and nuclear condensation, 
morphological hallmarks of programmed cell death. Further studies are required to 
determine the molecular mechanisms underlying the selective destruction of postnatal SGN 
and ANF in vitro and the reasons why postnatal hair cells are resistant to TMT. An 
important unanswered question is whether a development shift occurs in TMT toxicity such 
that hair cells become more vulnerable with advancing age due to neural myelination or 
developmental changes in the antioxidant enzymes expressed in hair cells and neurons.
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Representative confocal images showing cochlear organotypic cultures from the upper 
middle turn of the cochlea after 24 h in culture without (A) or (B) with TMT. Three rows of 
outer hair cells (OHC) and one row of inner hair cells (IHC) were immunolabeled with 
Alexa Fluor 568 conjugated phalloidin (red). Spiral ganglion neurons (SGN) and their nerve 
fibers (ANF) were immunolabeled with primary antibody against neurofilament 200 kD and 
Alexa Fluor488 conjugated secondary antibody (green). (A) Cochlear culture in control 
group. (B) Cochlear culture in group treated with 50 μM TMT. Note after TMT exposure 
ANF and SGN were severely destroyed, whereas cochlear hair cells were intact. Mean 
cochleograms (n=5) showing the percentage of missing OHCs and IHCs as a function of the 
percent distance from the apex of cochlea in the (C) Control group and the (D) group treated 
with 50 μM TMT for 24 h.
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Representative confocal images showing the condition of the peripheral auditory nerve 
fibers (ANF) from the upper middle turn of the cochlea. ANF in control group (A) and 
groups treated with indicated dose of TMT 24 h (B–E). (F) Mean (+SEM) numbers (n = 14/
group) of ANF/140 μm from the upper middle turn of the cochlea in control cultures and 
cultures treated with various concentrations of TMT for 24 h. Individual groups significantly 
different from one another (* p < 0.05).
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Representative confocal images showing the status of the spiral ganglion neurons (SGN) 
from the upper middle turn of the cochlea. SGN in control cultures (A) and cultures treated 
with indicated dose of TMT for 24 h (B–E). (F) Mean (+SEM) numbers (n=10/group) of 
SGN per 105μm3 from the upper middle turn of the cochlea in control cultures and cultures 
treated with various concentrations of TMT for 24 h. Individual groups significantly 
different from one anther (*p < 0.05).
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Typical confocal images showing morphological features of SGN in control culture and 
culture treated with 50 μM TMT for 24 h. SGN immunolabeled with Alexa Fluor488 
conjugated secondary antibody (green pseudo-color). Nuclei labeled with To-Pro-3 (red 
pseudo-color). (A) SGN in control cultures; short yellow arrows point to SGN soma; long 
yellow arrow point to ANF. (B) SGN in cultures treated with 50 μM TMT. TMT exposure 
induced significant SGN soma shrinkage and nuclear condensation (white arrows).
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Effect of TMT on SGN soma size. Distributions (n = 200 cells/group) of SGN soma size in 
control group (A) and cultures treated with TMT for 24 h; treatment/dose indicated below 
abscissa (B–E). (F) Mean (+/−SEM, n=200 cells) size of SGN soma in control cultures and 
cultures treated with various concentrations of TMT. Arrows/asterisks indicate significant 
between group differences (*p < 0.05).
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Representative confocal images of SGN showing caspase-3 labeling (pseudo-green) after 12 
h in culture. (A) Note absence of green label in negative control without caspase-3 probe. 
(B) Positive control with caspase-3 probe, but without TMT. (C) Caspase-3 label during 50 
μM TMT treatment. SGN labeled with antibody against neurofilament (pseudo-red); nuclei 
labeled with To-Pro-3 (blue), green caspase-3 labeling (pseudo-green). Dashed squares 
identify non-neuronal caspase-3 (pseudo-green) positive cells. Circles label neurofilament-
positive (red/reddish pink) SGN with shrunken soma and nuclei and green or yellow 
cytoplasmic labeling of caspase-3.
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